PROVIDER PROFILE · NPI 1578742888
Lily KaoMD
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
700
Unique beneficiaries
—
Total services
3,169
Distinct HCPCS
12
Medicare payment
$94K
Peer benchmark
Total Medicare services vs. 530 Rheumatology providers in CA — above median (cohort median 1,833).
PRESCRIBING · PART D · 2024
Total Rx claims
2,693
Beneficiaries
—
Total drug cost
$3.8M
Distinct drugs
39
Brand share
49.5%
Top prescribed drugs
Methotrexate Sodium618 claims
Hydroxychloroquine Sulfate227 claims
Alendronate Sodium184 claims
Leflunomide149 claims
Prednisone101 claims
QUALITY · MIPS · 2024
Final MIPS score
28.9
Quality
0.0
Cost
96.4
Improvement activities
0.0
Promoting interop.
0.0
Payment adjustment
-5.53%
Individual
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2025
Total received
$3K
Payment records
152
By payment type
Food and Beverage$3K
Top paying entities
Food and Beverage$3K
REFERRAL NETWORK
Where Lily Kao's patients come from & go
Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 3 inbound referrers · 0 outbound destinations.
Receives referrals from
Inbound — who sends patients here
| Physician | Patients | Visits |
|---|---|---|
| WEST COAST CLINICAL LABORATORIES, INC. | 69 | 152 |
| SAN JOSE HEALTHCARE SYSTEM, L.P. | 21 | 38 |
| NPI 1447682380 | 21 | 32 |
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
CROSS-REFERENCE